Gossamer Bio, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Gossamer Bio, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2023.
  • Gossamer Bio, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$2.56M, a 0.75% decline year-over-year.
  • Gossamer Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $190M, a 62.4% increase from 2022.
  • Gossamer Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $117M, a 3417% increase from 2021.
  • Gossamer Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $3.33M, a 98.9% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $190M +$73.1M +62.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $117M +$114M +3417% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $3.33M -$309M -98.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-05
2020 $313M -$9.04M -2.81% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-17
2019 $322M +$20.7M +6.89% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-03
2018 $301M +$295M +4914% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $6M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.